Tag: Drug Approvals
FDA Approves Epclusa for Chronic Hepatitis C
Combination drug treats six major strains of hepatitis C virus infection
FDA Approves Ocaliva for Primary Biliary Cholangitis
For patients who have not responded to, or cannot tolerate, ursodeoxycholic acid
FDA Approves Probuphine Implant for Opioid Dependence
New form of treatment designed to last six months
FDA Approves Probuphine Implant for Opioid Dependence
New form of treatment designed to last six months
FDA Approves Tecentriq to Treat Urothelial Carcinoma
FDA also approves a companion test to detect PD-L1 protein expression levels in patients
FDA Approves Nuplazid for Parkinson’s Hallucinations
Half of patients with Parkinson's may experience hallucinations, delusions
Doctors Can Be Misled About FDA ‘Breakthrough’ Drug Designation
Many believe meds supported by stronger evidence than the law requires to achieve designation
FDA Approves Venclexta for CLL With 17p Deletion
Drug sanctioned for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality
FDA Approves First Leadless Pacemaker
Eliminates need to repair wire lead in typical pacemakers that can malfunction
FDA Approves Inflectra as ‘Biosimilar’ to Remicade
For adults with Crohn's, rheumatoid arthritis, or psoriasis
